Simply in the past years, scientists have realized the huge function that the microbes living inside and on us play in our health. The human microbiome, and especially the gut microbiome, has actually been linked to multiple chronic diseases, including diabetes. An unbalanced microbiome composition has actually been discovered in patients with diabetes, who tend to have a less varied gut microbiome as compared to healthy individuals. Difference.
Some business are establishing diabetes treatments targeting the microbiome. The French Valviotis is presently carrying out preclinical screening of a drug focused on increasing the microbiome diversity as a treatment for type 2 diabetes. Although appealing, the microbiome field is very young and its complexity makes it challenging to establish causation after discovering correlation.
That world may not be so far away, as many business are establishing non-invasive techniques to substitute finger pricking. Difference. Integrity Applications has established a device called GlucoTrack that can measure glucose utilizing electro-magnetic waves and is currently readily available in Europe. Similar innovations are turning up, with GlucoSense in London utilizing laser light to measure sugar levels and MediWise using radio waves.
The GlucoWise sensing unit prototypePatches are likewise becoming a popular kind of determining blood glucose without needles, such as FreeStyle Libre, an inch-wide patch that can be used for approximately 2 weeks. At the University of Bath, researchers are establishing a graphene patch that could offer greater accuracy by determining sugar levels individually in several hair follicles – Difference.
Meanwhile, Senseonic and Roche are working on a device that is implanted under the skin. Difference. Still, non-invasive options to determine blood glucose often deal with issues regarding precision. The well-known glucose-measuring contact lens that Google revealed in 2014 was dismissed as “technically infeasible” and further developments will be needed to reach the degree of precision of finger-pricking methods.
Researchers are currently hypothesizing about microchips that can identify diabetes type 1 prior to the signs appear or nanorobots traveling in the bloodstream while they measure glucose and provide insulin – Difference.”There’s little fiction left in this. I highly think that microrobotics will come and will be part of our drug shipment within the next ten years,” said Tomas Landh, Director of Method and Innovation Sourcing at Novo Nordisk, at the 2013 Medicon Valley Alliance Yearly MeetingWhatever the future brings, it will unquestionably make a substantial distinction in the lives of countless individuals worldwide.